Sudan and South Sudan Pharmaceuticals & Healthcare Report Q2 2018

Sudan and South Sudan Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

Sudan continues to perpetuate a highly challenging environment for multinational drugmakers. While the removal ofrestrictions will improve Sudan's economic growth outlook and relations with the US, the operating environment remains highlychallenging and will continue to restrict company activity. Over the long term, a gradually improving business climate and Sudan'smore favourable position in the International community hold upside risk for pharmaceutical investment; however, the combinedeffects of country- and industry-specific risks are major deterrents for foreign drugmakers.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Industry Risk/Reward Index
Sub-Saharan Africa Pharmaceuticals: A Highly Challenging Region For Innovative Drugmakers
Sudan Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Demographic Forecast
Demographic Outlook 2017
Demographic Outlook 2017
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook